Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about FDA Approval

Recent news which mentions FDA Approval

FDA Bans Vuse Menthol E-Cigs: Why Some Vapes Like Elf Bars Avoid Scrutiny, Others Don't
Tickers BTI MO NFLX
Tags News FDA Approval General
From Benzinga
PharmaTher Holdings Nabs New Orphan Drug Status, Discusses Further Fast-Track, Partners For MDMA Patch
Tickers PHRRF RVVTF
Tags Orphan Drug Designation Markets RVVTF
From Benzinga
Bulls In A Bear Market: These 10 Stocks Clocked Gains In Excess Of 100% In 2022
Tickers AAPL ADMA AMPY ARDX
Tags Markets Analyst Color Biopharma
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
Tickers BGNE BIIB CDTX CHRS
Tags Biotech Small Cap CYTK
From Benzinga
Spectrum Gets FDA Nod For Febrile Neutropenia Candidate, Sees Commercial Launch In Q4 2022
Tickers SPPI
Tags General FDA Approval Movers & Shakers
From Benzinga
Revance Shares Shoot Higher As FDA Cleared DAXXIFY Injection For Frown Lines
Tickers RVNC
Tags RVNC News FDA Approval
From Benzinga
Sanofi's Rare Disease Drug Xenpozyme Scores FDA Approval
Tickers SNY
Tags Genetic Disease General FDA Approval
From Benzinga
Incyte Gets FDA Nod For Hematologic Malignancies Candidate
Tickers INCY
Tags Benzinga FDA Market News
From Benzinga
Axsome Shares Shoot Higher As FDA Approves Major Depressive Disorder Candidate
Tickers AXSM
Tags FDA Benzinga Market News
From Benzinga
Bluebird Secures FDA Nod For Genetic Blood Disease Candidate
Tickers BLUE
Tags Health Care General Movers & Shakers
From Benzinga
Arcutis Gets FDA Nod For Plaque Psoriasis Candidate, Sees Commercial Launch In Mid-August
Tickers ARQT
Tags Market News FDA Benzinga
From Benzinga
Horizon Therapeutics Receives FDA Approval For Uncontrolled Gout Candidate
Tickers HZNP
Tags FDA Approval HZNP Biotech
From Benzinga
FDA Green Lights Ceruvia's Phase 2 Psilocybin Trial Program For Obsessive-Compulsive Disorder Treatment
Tags Markets Startups News
From Benzinga
Cybin's Psilocybin Analog CYB003 Gets FDA Clearance For Trial To Potentially Treat Major Depressive Disorder
Tickers CYBN
Tags CYBN Legal General
From Benzinga
Rhythm Pharmaceuticals' Shares Dive Following FDA's Verdict On IMCIVREE Drug
Tickers RYTM
Tags FDA Benzinga RYTM
From Benzinga
U.S. FDA Approves Regeneron And Sanofi's Lead Drug For Skin Inflammation In Children
Tickers REGN SNY
Tags Market News Benzinga FDA
From Benzinga
Major Depressive Disorder Could Soon Have Treatment Option Via Cybin's Psilocybin Analog
Tickers CYBN
Tags FDA Approval News CYBN
From Benzinga
High Hopes For Alcohol Use Disorder Treatment: Clearmind's Successful Pre-IND Meeting With The FDA
Tickers CMNDF
Tags Benzinga Market News Cannabis
From Benzinga
Psychedelics Biotech Companies Mark New Milestones In Drug Development Pipelines: Field Trip, Cybin and Wesana
Tickers CYBN FTRP WSNAF
Tags Cannabis Market News WSNAF
From Benzinga
Boston Scientific's Exalt Model B Single-Use Bronchoscope Wins FDA Approval
Tickers BSX
Tags BSX Market News Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.